FDA Investigator Andrew K Haack, PhD

Andrew K Haack, PhD has inspections in 4 countries as of 19 Sep 2023. Andrew K Haack, PhD has collaborated with a combinined 3711 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
60
Last Inspection Date:
19 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100000845
Country:
United States of America, India, Korea (Republic of)
Co-Investigator(s):
A Williams, Abby M Miller, Alexander M Kay, Amanda L Fyles, Amy R Glynn, Anderson, Andrew "Drew" Haack, PhD, Andrew Haack, PhD, Anita Narula, PhD, Annette L Diggs, Astrida B Mattson, Avery J Dennis, Barbara Janine Breithaupt, Bichsa T Tran, Binh T Nguyen, Brenda K Alford, Brenda L Reihing, Brewer, Brian Janelsins, PhD, Bruce R Burrell, Bryan A Galvez, Camille Bennett Hoffman, Carl Lee, Carla J Lundi, Carr Sharpe, Caryn M Mcnab, Catherine J Laufmann, CDR Donald Ertel, CDR Rochelle B Young, RPh, MSA, Ce'nedra M Martin, Celena Ngo, Charles Yuanchia Kuo, PhD, Chava Kimchi Sarfaty, PhD, Chengjiu Hu, Christopher R Czajka, Christopher S Genther, Comyar Shoghi, Crystal A Harlan, Cynthia L Gorveatt, Dan C Fisher, Daniel J Roberts, Darren S Brown, David L Hunsaker, Dawn E Barkans, Deborah A Greco, Deborah M Trout, Dirk L Lincoln, Dogbeda F Mackenzie, Doretha M Tonkins, Doretha M Wilson, Dr. Monica D Cooper, Edward D Harris, Eileen A Liu, Elizabeth S Howell, Evelyn Wong, Farhana Khan, Gabriel M Guevarra, Gary C Pecic, Gavin W Pierce, Gina C Collins, Gloria J Baca, MS, Gunneet Kaur, Harmon M Blanch, Heika R Tait, Hoover, Hugh Grimoldby, Ian J Thomson, Indigo A Doll, Jacob N Hamilton, James A Lane, James R Fleckenstein, James S Cartwright, Jason T Lovelady, Jean Brewer, Jean R Mccurry, Jeanne M Weishaar, Jeffrey N Gerdes, Jennifer L Johnson, Jennifer M Gogley, Jessica B Clark, Jinkee Mvila Binayug, Joan Johnson, Joel D Hustedt, Joey V Quitania, John L Stevens, John R Myung, John T Sproul, Jolanna A Norton, Jonathan T Little, Joseph A Seitz, Joseph M Hudak, Juanita Banuelos, Jude C Dikes, Julia E Chervoni, Julian C Hanson, Kaarin M Slotte, Karthikeyan Kanakarajan (NMI), Katherine L Arnold, Kathryn A Krentz, Kathryn E King, Keegan B Mixon, Keith P Iams, Kelley, Kenneth O Gee, PhD, Kevin P Foley, Kevin T Gerrity, Kham Phommachanh, Kim Lthomas Cruse, Kimberly J Proctor Jones, Kirtida Patel, Kristina M Phelps, Langer, Lanita F Kelley, Lawrence Y Lee, PhD, Leon R Marquart, Lesley A Swanson, Lillian S Wu, Linda L Ng, Linda S Leja, Linda Thai, Lisa A Bowden, Lisa K Capron, Lisa T Michel, Lori J Silverstein, Lucila B Nwatu, Lydia S Chan, Marcus A Ray, Marcus F Yambot, Margo C Jones, Margo Cl Jones, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Mariza M Jafary, Mark E Imsland, Mark E Moen, Mark L Collins, Mark S Crippen, Mark W Babbitt, Marsha L Mccauley, Marshalette O Edwards, Mary R Hole, Maxyne Lam, Maxyne T Lam, Michael D Garcia, Michael J Donovan, Michael S Araneta, Michael T Cyrus, Miguel A Martinez, Mihaly S Ligmond, Mikel T Wright, Mikhail V Ovanesov, PhD, Mpris Inspector, Namcy E Byerly, Nancy E Byerly, Nataniel Phillips Sylvain, PhD, Naveen B Walker, Paul F Rader, Paul M Kawamoto, Peter E Baker, Peter Kessler, PhD, Peter T Regan, Prabhu P Raju, Rabia Ballica, PhD, Rachel J Cantrell, Randy L Self, Rebecca T Davis, Richard Ledwidge (nmi), PhD, Riley C Myers, PhD, Riley Meyers, Robert D Tollefsen, Ronald E Gill, S Lori Brown, PhD MPH, Sandra K Wangen, Sangeeta M Khurana, PhD, Sarah J Cullen, Savini, Scott W Fox, Selene T Torres, Sharon I Gundersen, Shelagh D Schopen, Sonya L Karsik, Stanley B Eugene, BS, BME, State Agency, Stephanie A Slater, MS, Sunitha K Rajaram, PhD, Susant Hadman, Taichun Qin, PhD, Tania Y Hall, Tara A Marshall, Tara M Pianko, Teegan Dellibovi Ragheb, PhD, Teresa T Cain, Terrance L Thomas, Terrence Gee, Terri L Dodds, Thao T Kwan, Uttaniti Limchumroon (Tom), V Teres Speer, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Vashti E Bocker, Vickie L Anderson, Virgilio F Pacio, CSO, Wayne D Stowell, Wayne E Seifert, Wilfred J Omoloh, William V Millar, Yasamin Ameri, Yideng Liang, Yuan Chia Kuo, Yvette Mlacour Davis, Yvonne C Wilkes, Zhong Li, PhD

Andrew K Haack, PhD's Documents

Publish Date Document Type Title
July, 2019 FDA 483 Picobio Co., Ltd - Form 483, 2019-07-05
November, 2016 FDA 483 Northern Fish Products Inc - Form 483, 2016-11-18
March, 2019 FDA 483 Intersect ENT, INC. - Form 483, 2019-03-06
September, 2018 FDA 483 Neutraderm, Inc. - Form 483, 2018-09-14
November, 2018 FDA 483 Laclede, Inc. - Form 483, 2018-11-07
April, 2019 FDA 483 OSRX Inc. - Form 483, 2019-04-25
February, 2023 EIR AGC Biologics, Inc. - EIR, 2023-09-18
June, 2019 FDA 483 Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center - Form 483, 2019-06-13
February, 2020 FDA 483 Mayon's Pharmaceuticals Private Limited - Form 483, 2020-02-20
September, 2019 FDA 483 Isorx Corp - Form 483, 2019-09-18
June, 2017 FDA 483 Shiraz Specialty Pharmacy, Inc. dba Axis Pharmacy Northwest - Form 483, 2017-06-15
February, 2019 EIR Alliance Medical Products, Inc. (dba Siegfried Irvine) - EIR, 2019-02-14
April, 2018 FDA 483 Dr Marcs Manufacturing and Sales, LLC - Form 483, 2018-04-27
July, 2019 FDA 483 GK Cosmetic Co., Ltd. - Form 483, 2019-07-19
July, 2016 FDA 483 Langenburg Water Company - Form 483, 2016-07-29
March, 2019 FDA 483 Response Intersect ENT, INC. - Form 483R, 2019-03-27
November, 2017 FDA 483 Dignity Health - Northridge Hospital Medical Center - Form 483, 2017-11-07
February, 2023 FDA 483 AGC Biologics, Inc. - Form 483, 2023-02-10
May, 2019 FDA 483 NeoBiotech Global Corporation - Form 483, 2019-05-13
February, 2019 FDA 483 Response Alliance Medical Products, Inc. (dba Siegfried Irvine) - Form 483R, 2019-03-07
July, 2019 FDA 483 C3 Co., Ltd. - Form 483, 2019-07-12
April, 2019 FDA 483 OLIVE BRANCH NATURAL BODY CARE LLC - Form 483, 2019-04-02
August, 2018 FDA 483 Auro Pharmacies, Inc. - Form 483, 2018-08-02
February, 2019 FDA 483 Alliance Medical Products, Inc. (dba Siegfried Irvine) - Form 483, 2019-02-14
February, 2018 FDA 483 HF Acquisition Co LLC - Form 483, 2018-02-09

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more